The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•23 April 2026•

1 min read

Boston Trust Walden Rebalances Portfolio with Major Amgen Buy and Lululemon Cut

Key Facts

1Boston Trust Walden Corp reduced its stake in lululemon athletica inc. by 10.2%, bringing its holdings to $22.79 million.

2The firm significantly increased its stake in Amgen Inc. by 390.1% following strong quarterly earnings and dividend announcements.

3Boston Trust Walden Corp increased its position in Fortinet, Inc. by 4.1%, totaling over $30 million in holdings.

Boston Trust Walden Corp has disclosed significant adjustments to its equity portfolio, highlighted by a 10.2% reduction in its stake in lululemon athletica inc., bringing the holding's value to $22.79 million. Conversely, the firm aggressively increased its position in Amgen Inc. by a staggering 390.1% following robust quarterly earnings and positive dividend announcements. Additionally, the firm raised its stake in Fortinet by 4.1%, with its total holdings in the cybersecurity firm now exceeding $30 million. These shifts reflect a strategic institutional rebalancing based on recent corporate performance and market sentiment. While LULU faced headwinds from executive changes and sluggish sales, AMGN and FTNT benefited from earnings beats that bolstered investor confidence. Overall, the moves signal a pivot toward biotechnology and cybersecurity amid shifting consumer retail dynamics.

Version History

1 additional source confirmed this story